Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Genetic Toxicology Testing Market By 2029?
The genetic toxicology testing market size has seen rapid growth in recent years. It is forecast to increase from $1.63 billion in 2024 to $1.8 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.2%. The expansion observed in the historical period is attributable to factors such as rising public health crises, increasing globalization, a greater focus on personalized medicine, an escalating demand for rigorous testing solutions, and a growing number of new drugs.
The genetic toxicology testing market is poised for significant expansion in the coming years, with its size anticipated to reach $2.56 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth throughout the forecast period stems from several key factors, including the increasing demand for novel food testing, growing apprehension regarding potential risks, escalating environmental and health concerns, heightened regulatory scrutiny, the expanded adoption of in vitro testing methods, and the emergence of high-throughput screening platforms. Key trends shaping this market during the forecast timeframe encompass advancements in precision medicine and toxicogenomics, an emphasis on comprehensive risk communication, evolution in genetic toxicology testing methodologies, progress in risk assessment methodologies, the incorporation of omics technologies, and breakthroughs in genomics and molecular biology.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15574&type=smp
What Are The Top Growth Drivers Impacting The Genetic Toxicology Testing Market Outlook?
The future expansion of the genetic toxicology testing market is anticipated due to the rising need for personalized medicine. This medical approach involves customizing healthcare choices, methods, treatments, and goods for each patient, considering their anticipated reaction or vulnerability to illness. The personalized medicine market has seen significant positive development, driven by advancements in genetics, enhanced disease comprehension, accessible diagnostic tools relying on biomarkers, value-focused healthcare programs, and its incorporation into clinical settings and research. Genetic toxicology testing aids personalized medicine by offering crucial data concerning genetic variations, vulnerability to genotoxic substances, and how patients respond to treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized medicines for rare disease patients in 2023, an increase from six in 2022. Consequently, the growing requirement for personalized medicine is a key impetus for the genetic toxicology testing market.
How Is The Genetic Toxicology Testing Market Segmented?
The genetic toxicology testingmarket covered in this report is segmented –
1) By Type: In Vitro; In Vivo
2) By Product: Services; Reagents And Consumables; Assays
3) By Application: Healthcare Industry; Food Industry; Cosmetics Industry; Agriculture Industry; Other Applications
Subsegments:
1) By In Vitro: Ames Test; Micronucleus Assay; Comet Assay; Chromosomal Aberration Test; Cell Transformation Assay; Other In Vitro Methods
2) By In Vivo: Micronucleus Test (Rodent); Comet Assay (In Vivo); Bone Marrow Chromosomal Aberration Test; Dominant Lethal Test (Rodent); Other In Vivo Methods
What Trends Are Expected To Drive The Genetic Toxicology Testing Market?
Companies operating in the genetic toxicology testing market are focusing on the creation of innovative drug screening platforms, such as phenotypic drug screening, to improve the accuracy and efficiency in identifying potential genetic toxins. Phenotypic drug screening is an approach utilized in drug discovery where compounds are assessed based on their ability to produce a specific cellular or physiological response in a whole organism or a relevant cell system. For instance, in August 2022, Creative Biogene, a US-based biotechnology company, launched zebrafish disease models to aid drug discovery and toxicology research. These models are designed to mimic human genetic diseases in zebrafish, offering insights into disease pathogenesis, drug discovery, and toxicology. Creative Biogene’s zebrafish models provide a valuable platform for evaluating drug toxicity, predicting the safety of new compounds, and supporting the drug development process.
Which Major Firms Are Strengthening Their Position In The Genetic Toxicology Testing Industry?
Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Genetic Toxicology Testing Market?
North America was the largest region in the genetic toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Genetic Toxicology Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15574&type=smp
Browse Through More Reports Similar to the Global Genetic Toxicology Testing Market 2025, By The Business Research Company
Genetic Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Direct To Consumer Dtc Genetic Testing Global Market Report 2025
In Vitro Toxicology Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model